EP1445327A4 - Screeningverfahren für einen auf die zellwand wirkenden arzneistoff - Google Patents

Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Info

Publication number
EP1445327A4
EP1445327A4 EP02775378A EP02775378A EP1445327A4 EP 1445327 A4 EP1445327 A4 EP 1445327A4 EP 02775378 A EP02775378 A EP 02775378A EP 02775378 A EP02775378 A EP 02775378A EP 1445327 A4 EP1445327 A4 EP 1445327A4
Authority
EP
European Patent Office
Prior art keywords
cell wall
reporter protein
targeting site
agent
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP02775378A
Other languages
English (en)
French (fr)
Other versions
EP1445327A1 (de
EP1445327B1 (de
Inventor
Akihiro Kitamura
Ryohei Nakajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of EP1445327A1 publication Critical patent/EP1445327A1/de
Publication of EP1445327A4 publication Critical patent/EP1445327A4/de
Application granted granted Critical
Publication of EP1445327B1 publication Critical patent/EP1445327B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP02775378A 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff Expired - Lifetime EP1445327B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001323293 2001-10-22
JP2001323293 2001-10-22
PCT/JP2002/010932 WO2003035898A1 (fr) 2001-10-22 2002-10-22 Methode de criblage d'un medicament agissant sur la paroi cellulaire

Publications (3)

Publication Number Publication Date
EP1445327A1 EP1445327A1 (de) 2004-08-11
EP1445327A4 true EP1445327A4 (de) 2005-09-14
EP1445327B1 EP1445327B1 (de) 2007-08-15

Family

ID=19140207

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02775378A Expired - Lifetime EP1445327B1 (de) 2001-10-22 2002-10-22 Screeningverfahren für einen auf die zellwand wirkenden arzneistoff

Country Status (9)

Country Link
US (1) US7459268B2 (de)
EP (1) EP1445327B1 (de)
JP (1) JP4204471B2 (de)
AT (1) ATE370243T1 (de)
CA (1) CA2464396A1 (de)
DE (1) DE60221883T2 (de)
ES (1) ES2294172T3 (de)
NO (1) NO20042089L (de)
WO (1) WO2003035898A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035898A1 (fr) 2001-10-22 2003-05-01 Daiichi Pharmaceutical Co., Ltd. Methode de criblage d'un medicament agissant sur la paroi cellulaire
US20090274794A1 (en) * 2005-09-22 2009-11-05 Suntory Limited Gene Encoding Cell Wall Mannoprotein and use Thererof
TWI428091B (zh) * 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
CN115094142B (zh) * 2022-07-19 2024-05-28 中国医学科学院肿瘤医院 用于诊断肺肠型腺癌的甲基化标志物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067419A1 (en) * 1998-06-25 1999-12-29 The Collaborative Group, Ltd. β(1,6)-GLUCAN SYNTHESIS AND CELL WALL ASSEMBLY ASSAY
EP1283261A1 (de) * 2000-05-01 2003-02-12 Daiichi Pharmaceutical Co., Ltd. Verfahren zum screening von auf zellwände wirkenden arzneistoffen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950702634A (ko) * 1992-07-08 1995-07-29 이. 아디에 융합 단백질을 생성시킴으로써 미생물 세포의 세포벽에 효소를 고정화시키는 방법(Process for Immobilizing Enzymes to the Cell Wall of a Microbial Cell by Producing a Fusion Protein)
JPH0956384A (ja) 1995-08-25 1997-03-04 Toray Ind Inc 細胞の標識方法
EP0916726A1 (de) 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
JP2000102387A (ja) 1998-09-29 2000-04-11 Daicel Chem Ind Ltd 発光蛋白質発現組換えベクター、及びこの組換えベクターにより形質転換された酵母
WO2003035898A1 (fr) 2001-10-22 2003-05-01 Daiichi Pharmaceutical Co., Ltd. Methode de criblage d'un medicament agissant sur la paroi cellulaire

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999067419A1 (en) * 1998-06-25 1999-12-29 The Collaborative Group, Ltd. β(1,6)-GLUCAN SYNTHESIS AND CELL WALL ASSEMBLY ASSAY
EP1283261A1 (de) * 2000-05-01 2003-02-12 Daiichi Pharmaceutical Co., Ltd. Verfahren zum screening von auf zellwände wirkenden arzneistoffen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LU CHA-FEN ET AL: "Glycosyl phosphatidylinositol-dependent cross-linking of alpha-agglutinin and beta-1,6-glucan in the Saccharomyces cerevisiae cell wall", JOURNAL OF CELL BIOLOGY, vol. 128, no. 3, 1995, pages 333 - 340, XP002336721, ISSN: 0021-9525 *
SHAHINLAN S ET AL: "BETA-1,6-GLUCAN SYNTHESIS IN SACCHAROMYCES CEREVISIAE", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 35, no. 3, 2000, pages 477 - 489, XP001053225, ISSN: 0950-382X *

Also Published As

Publication number Publication date
JPWO2003035898A1 (ja) 2005-02-10
ES2294172T3 (es) 2008-04-01
US20050069965A1 (en) 2005-03-31
NO20042089L (no) 2004-05-21
EP1445327A1 (de) 2004-08-11
CA2464396A1 (en) 2003-05-01
WO2003035898A1 (fr) 2003-05-01
ATE370243T1 (de) 2007-09-15
DE60221883T2 (de) 2008-04-30
US7459268B2 (en) 2008-12-02
JP4204471B2 (ja) 2009-01-07
DE60221883D1 (de) 2007-09-27
EP1445327B1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
HK1094231A1 (en) Prebiotic effect analysis
ATE431427T1 (de) Verbessertes verfahren zum nachweis von atp
CA2410533A1 (en) A method and apparatus for detecting lameness in animals
MXPA03000226A (es) Diagnosticos tempranos de enfermedades conformacionales.
ITTO20010411A0 (it) Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti.
ATE496288T1 (de) Gleichzeitige mehrfachanalyse klinischer proben
DE60142048D1 (de) Universelles sammelmedium
WO2004083816A3 (en) Loss of heterozygosity of the dna markers in the 12q22-23 region
ATE330032T1 (de) Verfahren zur erhaltung der dns-integrität
WO2004055519A3 (en) Specific markers for pancreatic cancer
WO2007006661A3 (en) System and method for characterizing a chemical sample
GB2410798A (en) Methods detecting, characterising and monitoring hydrocarbon reservoirs
EP2107482A3 (de) Verfahren und System zur Analyse von Reaktionen mittels eines Informationssystems
EP1065213A3 (de) HCV Polymerase die für eine Krystalstruktur Analyse geeignet ist, und Verfahren zur Benutzung diesem Enzym
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
WO2002066975A3 (en) Tissue-based water quality biosensors for detecting chemical warfare agents
EP1445327A4 (de) Screeningverfahren für einen auf die zellwand wirkenden arzneistoff
ATE487797T1 (de) Verfahren zum nachweis von transferase- enzymaktivität
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
NO20025217D0 (no) FremgangsmÕte for screening av legemiddel som virker pÕ cellevegg
EP2407787A3 (de) Verfahren für den Nachweis von L523S-Expression in biologischen Proben
WO2005035785A3 (fr) Methode de detection rapide de micro-organismes sur puces a adn
WO2004055200A3 (en) Methods for screening compounds for use in the treatment of disease
DK1192460T3 (da) Fremgangsmåde til påvisning af mastitis
EA200000500A1 (ru) Способ испытания средства защиты на функционирование

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040429

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 31/10 B

Ipc: 7C 12Q 1/02 A

Ipc: 7G 01N 33/50 B

Ipc: 7A 61K 45/00 B

Ipc: 7C 12Q 1/18 B

Ipc: 7G 01N 33/15 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050729

17Q First examination report despatched

Effective date: 20060220

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAC Information related to communication of intention to grant a patent modified

Free format text: ORIGINAL CODE: EPIDOSCIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DALICHI SANKYO COMPANY, LIMITED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: DAIICHI SANKYO COMPANY, LIMITED

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60221883

Country of ref document: DE

Date of ref document: 20070927

Kind code of ref document: P

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: DAIICHI SANKYO COMPANY, LIMITED

Effective date: 20070919

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: DAIICHI SANKYO COMPANY, LIMITED

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: ISLER & PEDRAZZINI AG

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: DAIICHI SANKYO COMPANY, LIMITED

Effective date: 20071107

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071115

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2294172

Country of ref document: ES

Kind code of ref document: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071116

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071031

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20080115

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20080516

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071022

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071022

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070815

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20091014

Year of fee payment: 8

Ref country code: DE

Payment date: 20091015

Year of fee payment: 8

Ref country code: ES

Payment date: 20091023

Year of fee payment: 8

Ref country code: SE

Payment date: 20091007

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20091015

Year of fee payment: 8

Ref country code: BE

Payment date: 20090917

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20091029

Year of fee payment: 8

Ref country code: GB

Payment date: 20091021

Year of fee payment: 8

Ref country code: IT

Payment date: 20091020

Year of fee payment: 8

BERE Be: lapsed

Owner name: DAIICHI SANKYO COMPANY, LTD

Effective date: 20101031

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20110501

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20101022

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101102

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101031

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101031

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20110630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110501

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101022

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101031

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60221883

Country of ref document: DE

Effective date: 20110502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101023

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20111118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101022

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20101023

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110502